Home / Site Map
Site Map
A complete index of every page on this site — products, guides, comparisons, and more.
Main Pages
Peptide Comparisons
Peptide Guides
- All Peptide Guides
- Claviculars Peptides Review: Inside the 143-Compound Research Catalog— 10 min read
- What Looksmaxxing Influencers Are Actually Using: Peptide Protocols Breakdown— 12 min read
- Clavicular Width & Frame Looksmaxxing: What the Research Says About Peptides— 11 min read
- Bone Structure Looksmaxxing: Jaw, Frame, and Skeletal Research with Peptides— 13 min read
- Retatrutide: The Triple GLP-1/GIP/Glucagon Agonist Peptide — Research Guide— 10 min read
- Peptides for Sleep Optimization: Epithalon, CJC-1295 & Ipamorelin Protocol— 10 min read
- Peptides for Men: The Complete Male Optimization Stack Guide for Looksmaxxing— 12 min read
- Peptide Side Effects: What to Expect From Research Peptides (Complete Guide)— 11 min read
- Melanotan 2 (MT-2) Research Guide: Tanning, Mechanism & Protocol— 9 min read
- BPC-157 Oral vs Injectable: Which Form Works for Your Research Goal?— 9 min read
- AOD-9604 (HGH Fragment 176-191): The Targeted Fat Loss Peptide Research Guide— 9 min read
- Body Recomposition Peptide Stack for Looksmaxxing: GH, Fat Loss & Lean Mass— 11 min read
- Peptides for Hair Growth & Looksmaxxing: GHK-Cu, TB-500 & BPC-157 Protocol— 9 min read
- GHK-Cu for Skin Looksmaxxing: Collagen, Elastin & Appearance Protocol— 10 min read
- How to Reconstitute & Store Studies Peptides: Complete Guide— 7 min read
- Semaglutide Studies Overview: GLP-1 Agonist Science— 9 min read
- Epithalon: Telomere Studies & Longevity Science— 9 min read
- Semax: The Nootropic Peptide for Cognitive Research— 8 min read
- Looksmaxxing with Peptides: The Complete Studies Guide— 12 min read
- MK-677 (Ibutamoren): Oral GH Secretagogue Studies Guide— 9 min read
- Tirzepatide Studies Overview: Dual GIP/GLP-1 Agonist— 10 min read
- Ipamorelin Studies Guide: Selective GH Secretagogue— 8 min read
- GHK-Cu (Copper Peptide): Anti-Aging Studies & Applications— 9 min read
- CJC-1295 + Ipamorelin Stack: The Ultimate GH Peptide Protocol— 11 min read
- BPC-157 Dosage Guide: Studies Protocols & Administration— 8 min read
- TB-500 (Thymosin Beta-4): Studies Benefits & Dosing Guide— 9 min read
- BPC-157: The Complete Studies Guide (2025)— 10 min read
All Products
Healing & Recovery
- BPC-157 10mg— 250–500 mcg/day subcutaneous or intramuscular
- BPC-157 Capsules 500mcg x60— 500–1000 mcg orally per day
- TB-500 (Thymosin Beta-4) 10mg— 2–2.5 mg twice per week subcutaneous
- ARA-290 10mg— 4 mcg/kg subcutaneous daily for cycles
- Bronchogen 20mg— 5–10 mg subcutaneous daily for 10–20 day cycles
- Cardiogen 20mg— 5–10 mg subcutaneous daily for 10–20 day cycles
- Cartalax 20mg— 5–10 mg subcutaneous daily for 10–20 day cycles
- Chonluten 20mg— 5–10 mg subcutaneous daily for 10–20 day cycles
- Cortagen 20mg— 5–10 mg subcutaneous daily for 10–20 day cycles
- Crystagen 20mg— 5–10 mg subcutaneous daily for 10–20 day cycles
- KPV 10mg— 100–500 mcg subcutaneous or oral daily
- KPV 5mg— 100–300 mcg subcutaneous or oral daily
- Livagen 20mg— 5–10 mg subcutaneous daily for 10–20 day cycles
- Ovagen 20mg— 5–10 mg subcutaneous daily for 10–20 day cycles
- Oxytocin 10mg— 10–40 IU intranasal or 1–2 mg subcutaneous
- Oxytocin 8mg— 10–40 IU intranasal or 1–2 mg subcutaneous
- Pancragen 20mg— 5–10 mg subcutaneous daily for 10–20 day cycles
- Prostamax 20mg— 5–10 mg subcutaneous daily for 10–20 day cycles
- SS-31 10mg— 1–10 mg subcutaneous daily
- SS-31 25mg— 1–10 mg subcutaneous daily
- SS-31 50mg— 1–10 mg subcutaneous daily
- Testagen 20mg— 5–10 mg subcutaneous daily for 10–20 day cycles
- Vesilute 20mg— 5–10 mg subcutaneous daily for 10–20 day cycles
- Vesugen 20mg— 5–10 mg subcutaneous daily for 10–20 day cycles
- Vilon 20mg— 5–10 mg subcutaneous daily for 10–20 day cycles
- VIP 10mg— 25–100 mcg subcutaneous or IV daily
- VIP 5mg— 25–100 mcg subcutaneous or IV daily
Immune
Metabolic
- MOTS-c 10mg— 5–10 mg 3x per week subcutaneous
- MOTS-c 20mg— 5–20 mg 3x per week subcutaneous
- MOTS-c 40mg— 5–20 mg 3x per week subcutaneous
- 5-Amino-1MQ 5mg— 50–100 mg orally 1–3x daily
- 5-Amino-1MQ 50mg— 50–100 mg orally 1–3x daily
- 5-Amino-1MQ 50mg x60 Capsules— 50–100 mg (1–2 capsules) 1–3x daily
- AICAR 50mg— 250–500 mg subcutaneous daily
- AOD9604 2mg— 300–500 mcg subcutaneous daily
- AOD9604 5mg— 300–500 mcg subcutaneous daily
- AOD9604 10mg— 300–500 mcg subcutaneous daily
- Adipotide (FTPP) 5mg— 100–300 mcg/kg subcutaneous daily
- Adipotide (FTPP) 10mg— 100–300 mcg/kg subcutaneous daily
- BAM-15 30mg/mL 30mL— Variable per research protocol — solution form
- BAM-15 50mg/mL 30mL— Variable per research protocol — higher concentration
- Cagrilintide 5mg— 0.3–4.5 mg weekly subcutaneous
- Cagrilintide 10mg— 0.3–4.5 mg weekly subcutaneous
- L-Carnitine 400mg/mL— 1–3 g (2.5–7.5 mL) subcutaneous or IV daily
- L-Carnitine 600mg/mL— 1–3 g subcutaneous or IV daily
- L-Carnitine 5-Pack 600mg— 1–3 g subcutaneous or IV daily
- Mazdutide 6mg— 3–9 mg weekly subcutaneous
- O-304 (ATX-304) 100mg x60 Capsules— 100–400 mg orally daily (1–4 capsules)
- Retatrutide 10mg— 2–12 mg weekly subcutaneous
- Retatrutide 15mg— 4–12 mg weekly subcutaneous
- Retatrutide 20mg— 4–12 mg weekly subcutaneous
- Retatrutide 30mg— 4–12 mg weekly subcutaneous
- Semaglutide 3mg— 0.25–2.4 mg weekly subcutaneous (dose escalation)
- Semaglutide 6mg— 0.25–2.4 mg weekly subcutaneous
- Semaglutide 12mg— 0.25–2.4 mg weekly subcutaneous
- Semaglutide 20mg— 0.25–2.4 mg weekly subcutaneous
- Semaglutide 30mg— 0.25–2.4 mg weekly subcutaneous
- SLU-PP-332 1mg x30 Capsules— 1–100 mg orally daily
- SLU-PP-332 100mg x30 Capsules— 100 mg orally daily (1 capsule)
- SLU-PP-332 100mg x120 Capsules— 100 mg orally daily (1 capsule)
- SLU-PP-332 1mg/mL 30mL— Variable per research protocol
- SLU-PP-332 5mg/mL 30mL— Variable per research protocol
- Survodutide 10mg— 0.6–6 mg weekly subcutaneous
- Tesofensine 500mcg x30 Capsules— 0.25–1 mg orally daily
- Tesofensine 500mcg x30 Tablets— 0.25–1 mg orally daily
- Tirzepatide 15mg— 2.5–15 mg weekly subcutaneous (dose escalation)
- Tirzepatide 30mg— 2.5–15 mg weekly subcutaneous
- Tirzepatide 60mg— 2.5–15 mg weekly subcutaneous
Supplies
Growth Hormone
- CJC-1295 No DAC 10mg— 100–200 mcg subcutaneous 2–3x per week
- CJC-1295 No DAC 5mg— 100–200 mcg subcutaneous 2–3x per week
- CJC-1295 with DAC 10mg— 1–2 mg subcutaneous once or twice per week
- GHRP-2 10mg— 100–300 mcg subcutaneous 2–3x daily
- GHRP-6 10mg— 100–300 mcg subcutaneous 2–3x daily
- Gonadorelin Acetate— 100–500 mcg subcutaneous 2–3x per week
- Hexarelin 5mg— 100–200 mcg subcutaneous 2–3x daily
- IGF-1 LR3 1mg— 40–100 mcg subcutaneous daily
- Ipamorelin 10mg— 200–300 mcg subcutaneous 2–3x daily
- PEG-MGF 2mg— 200–400 mcg subcutaneous 2–3x per week
- Sermorelin 2mg— 200–500 mcg subcutaneous before bed
- Sermorelin 5mg— 200–500 mcg subcutaneous before bed
- Sermorelin 10mg— 200–500 mcg subcutaneous before bed
- Tesamorelin 10mg— 1–2 mg subcutaneous daily
- Tesamorelin 20mg— 1–2 mg subcutaneous daily
Melanocortin
Anti-Aging
- Abaloparatide 3mg— 80 mcg subcutaneous daily
- ACE-031 1mg— 1–3 mg/kg monthly subcutaneous
- Epitalon 10mg— 5–10 mg/day subcutaneous for 10–20 day cycles
- Epitalon 50mg— 5–10 mg/day subcutaneous for 10–20 day cycles
- FOXO4-DRI 10mg— 1–5 mg/kg subcutaneous 3x per week for cycles
- GHK-Cu 50mg— 1–2 mg/day subcutaneous or topical
- GHK-Cu 100mg— 1–2 mg/day subcutaneous or topical
- Glutathione 200mg— 200–600 mg subcutaneous or IV
- Glutathione 600mg— 600 mg subcutaneous or IV 2–3x per week
- Glutathione 1500mg— 1000–1500 mg IV or subcutaneous per session
- Methylene Blue 10mg/mL 50mL— 0.5–4 mg/kg orally or IV
- NA-Epitalon 10mg— 5–10 mg/day subcutaneous for 10–20 day cycles
- NAD+ 500mg— 250–500 mg IV or subcutaneous per session
- NAD+ 1000mg— 500–1000 mg IV per session
- P21 10mg— 50–100 mcg/kg subcutaneous daily
- PNC-27 30mg— 1–5 mg/kg per research protocol
- RU-58841 50mg x30mL— Apply 1 mL (50 mg) topically to scalp daily
- RU-58841 50mg x60mL— 1 mL (50 mg) applied topically to scalp daily
- SNAP-8 10mg— 4–10 mcg/mL topically or subcutaneous per site
Cognitive
- Adamax 10mg— 100–300 mcg intranasally or subcutaneous daily
- DSIP 5mg— 200–400 mcg subcutaneous before bed
- DSIP 10mg— 200–400 mcg subcutaneous before bed
- DSIP 15mg— 200–400 mcg subcutaneous before bed
- N-Acetyl Semax Amidate 30mg— 100–400 mcg intranasally or subcutaneous daily
- NA-Selank Amidate 10mg— 100–500 mcg intranasally daily
- NA-Selank Amidate 30mg— 100–500 mcg intranasally daily
- PE-22-28 10mg— 50–200 mcg subcutaneous daily
- Pinealon 10mg— 5–10 mg subcutaneous daily for 10–20 day cycles
- Pinealon 20mg— 5–10 mg subcutaneous daily for 10–20 day cycles
- Selank 10mg— 250–500 mcg intranasally or subcutaneous 1–2x daily
Bundle
- BPC-157 + TB-500 Blend 10mg— BPC-157: 250 mcg + TB-500: 1.25 mg co-administered daily
- BPC-157 + TB-500 Blend 20mg— BPC-157: 500 mcg + TB-500: 2.5 mg co-administered per session
- Cagri-Reta 5mg— Per research protocol — combination dosing
- Cagri-Reta 10mg— Per research protocol — higher dose combination
- CagriSema Blend 10mg— Cagrilintide 2.4 mg + Semaglutide 2.4 mg weekly
- GLOW Blend 50mg— Per Phiogen protocol — subcutaneous or topical
- GLOW Blend 70mg— Per Phiogen protocol — subcutaneous or topical
- IPA/TESA Blend 15mg— Ipamorelin 200 mcg + Tesamorelin 1 mg co-administered
- Ipamorelin/CJC-1295 Blend 10mg— Co-administer 100–200 mcg CJC + 200–300 mcg Ipa subcutaneous
- Ipamorelin/CJC-1295 Blend 10mg v2— Co-administer 100–200 mcg CJC + 200–300 mcg Ipa subcutaneous
- Ipamorelin/Tesamorelin Blend 13mg— Ipamorelin 150 mcg + Tesamorelin 1 mg co-administered
- Ipamorelin/Tesamorelin Blend 15mg— Ipamorelin 250 mcg + Tesamorelin 1 mg co-administered
- KLOW Blend 80mg— Per Phiogen protocol
- Reta-Cagri 5mg/5mg— Per research protocol — weekly subcutaneous
Looking for the machine-readable sitemap? View sitemap.xml →